Business Description
China Health Technology Group Holding Co Ltd
ISIN : KYG2152L1169
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.07 | |||||
Debt-to-Equity | 9.19 | |||||
Debt-to-EBITDA | 0.58 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -3.43 | |||||
Beneish M-Score | 5.1 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.8 | |||||
3-Year EPS without NRI Growth Rate | 62.6 | |||||
3-Year Book Growth Rate | -75.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.72 | |||||
9-Day RSI | 39.03 | |||||
14-Day RSI | 39.22 | |||||
6-1 Month Momentum % | -47.95 | |||||
12-1 Month Momentum % | -44.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.96 | |||||
Quick Ratio | 0.93 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 9.34 | |||||
Days Sales Outstanding | 72.8 | |||||
Days Payable | 20.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -86.6 | |||||
Shareholder Yield % | 808.38 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 4.09 | |||||
Operating Margin % | -44 | |||||
Net Margin % | 424.2 | |||||
FCF Margin % | 60.34 | |||||
ROE % | Neg. Equity | |||||
ROA % | 131.19 | |||||
ROIC % | -8.3 | |||||
ROC (Joel Greenblatt) % | 447.6 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 0.01 | |||||
Price-to-Owner-Earnings | 0.11 | |||||
PS Ratio | 0.1 | |||||
PB Ratio | 1.8 | |||||
Price-to-Tangible-Book | 1.8 | |||||
Price-to-Free-Cash-Flow | 0.38 | |||||
Price-to-Operating-Cash-Flow | 0.38 | |||||
EV-to-EBIT | 0.7 | |||||
EV-to-EBITDA | 0.7 | |||||
EV-to-Revenue | 3.01 | |||||
EV-to-FCF | 5.02 | |||||
Price-to-Projected-FCF | 0.36 | |||||
Price-to-Median-PS-Value | 0.03 | |||||
Earnings Yield (Greenblatt) % | 142.86 | |||||
FCF Yield % | 100.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
China Health Technology Group Holding Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 51.578 | ||
EPS (TTM) (HK$) | 3.51 | ||
Beta | 0.3 | ||
Volatility % | 104.31 | ||
14-Day RSI | 39.22 | ||
14-Day ATR (HK$) | 0.004054 | ||
20-Day SMA (HK$) | 0.0376 | ||
12-1 Month Momentum % | -44.12 | ||
52-Week Range (HK$) | 0.032 - 0.115 | ||
Shares Outstanding (Mil) | 859.24 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
China Health Technology Group Holding Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
China Health Technology Group Holding Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
China Health Technology Group Holding Co Ltd Frequently Asked Questions
What is China Health Technology Group Holding Co Ltd(HKSE:01069)'s stock price today?
When is next earnings date of China Health Technology Group Holding Co Ltd(HKSE:01069)?
Does China Health Technology Group Holding Co Ltd(HKSE:01069) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |